BCAL Diagnostics Limited (AU:BDX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BCAL Diagnostics Limited has announced a new application for the quotation of securities, signaling a fresh financial move in the stock market. A total of 62 million ordinary fully paid shares will be quoted under the ASX security code BDX, effective from June 11, 2024. This move could indicate an expansion or new venture for the company, catching the interest of current and potential investors.
For further insights into AU:BDX stock, check out TipRanks’ Stock Analysis page.